My watch list
my.bionity.com  
Login  

54 Current news about the topic bioavailability

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
An effective approach to optimizing medicinal molecules

16-Aug-2018

The search for new medicinal molecules with predetermined properties is a rather complex, expensive and time-consuming process, especially in oncology. Modern science allows us to accelerate this search through the use of computer technology and the introduction of automated processes. In the ...

more

image description
Adjustment of drug dose for rheumatoid arthritis by diagnostic method

Determination of the therapeutic window of adalimumab

06-Oct-2017

Collaboration between the Immanuel Klinikum Bernau Herzzentrum Brandenburg, the Rheumazentrum Nord-Brandenburg and BioTeZ demonstrates new ways of treating rheumatoid arthritis. Through the introduction of therapeutic antibodies, the treatment results for rheumatoid arthritis (RA) have been ...

more

Lonza Acquires Micro-Macinazione

Swiss company expert in the field of microniziation

07-Aug-2017

Lonza has acquired Micro-Macinazione, providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro-Macinazione, which had sales of ~ CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Micro-Macinazione was purchased from ...

more

Micron-sized hydrogel cubes show highly efficient delivery of a potent anti-cancer drug

30-Jun-2017

Many potent anti-cancer drugs have major drawbacks -- they fail to mix with water, which means they will have a limited solubility in blood, and they lack selectivity to cancer cells. Researchers at the University of Alabama at Birmingham and Texas Tech University Health Sciences Center have ...

more

image description
New perspective for soil clean-up

Microscopic ciliates transport poisonous tar substances

26-Mar-2014

You must use a microscope to spot the new helpers that can assist in biological soil clean-up (bioremediation). They are small, mobile microorganisms, such as the unicellular slipper-shaped ciliates that can be found in stale water in a flower vase, where they feed on bacteria. New results from ...

more

BASF and Catalent join forces to solve bioavailability challenges

10-Apr-2012

Catalent Pharma Solutions and BASF have entered into a broad collaboration and Open Alliance to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges. The companies aim to combine their expertise to provide pharmaceutical ...

more

Quotient Clinical and Bend Research Announce Collaboration To Accelerate Advancement of New Medicines

15-Nov-2010

Bend Research Inc. and Quotient Clinical, a business unit of Quotient Bioresearch, announced a nonexclusive collaboration that can speed the advance of compounds to clinical trials and expand options for drug delivery. The collaboration combines Bend Research’s advanced drug formulation ...

more

Hybrigenics develops new oral formulations of inecalcitol

Hybrigenics seeks patent protection until 2030 for innovative oral formulations optimized for the delivery of high doses of inecalcitol

04-Nov-2010

Hybrigenics announced the filing of a patent application covering new soft gelatin capsules, tablets or drinking solutions optimized for the delivery of high doses of inecalcitol. This pharmaceutical optimization followed the demonstration of safety and the presumption of efficacy of oral doses ...

more

SoluBest and Dr. Reddy´s Sign Drug Delivery Collaboration to Develop New, Proprietary Formulations

08-Oct-2010

SoluBest has closed a collaboration agreement with Dr. Reddy's Laboratories Ltd. to develop a new, proprietary formulation of one of SoluBest’s pipeline compound.. In return, SoluBest is eligible to upfront, research and milestone and significant royalty payments. Further financial details have ...

more

Glycotope received regulatory approval for glycooptimized and fully human glycosylated antibody CetuGEX

13-Aug-2010

Glycotope GmbH, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope's next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers. “For Glycotope, the approval of CetuGEX, our 2nd antibody in the clinic, ...

more

Page 1 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE